Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Long-Term Investments (2016 - 2025)

Sanofi (SNY) has disclosed Long-Term Investments for 11 consecutive years, with $3.8 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 1023.45% to $3.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 billion through Dec 2025, up 1023.45% year-over-year, with the annual reading at $3.7 billion for FY2025, 976.56% up from the prior year.
  • Long-Term Investments hit $3.8 billion in Q4 2025 for Sanofi, up from $337.7 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $3.8 billion in Q4 2025 to a low of $286.0 million in Q4 2021.
  • Historically, Long-Term Investments has averaged $1.1 billion across 5 years, with a median of $456.2 million in 2023.
  • Biggest five-year swings in Long-Term Investments: tumbled 33.95% in 2023 and later skyrocketed 1023.45% in 2025.
  • Year by year, Long-Term Investments stood at $286.0 million in 2021, then surged by 141.51% to $690.7 million in 2022, then plummeted by 33.95% to $456.2 million in 2023, then fell by 25.98% to $337.7 million in 2024, then surged by 1023.45% to $3.8 billion in 2025.
  • Business Quant data shows Long-Term Investments for SNY at $3.8 billion in Q4 2025, $337.7 million in Q4 2024, and $456.2 million in Q4 2023.